辰欣药业(603367.SH)：石四药累计减持0.998%公司股份

Group 1 - The core point of the article is that Chenxin Pharmaceutical (603367.SH) has completed a share reduction plan initiated by Shisi Pharmaceutical, resulting in a total reduction of 4.52 million shares, which represents 0.998% of the company's total share capital [1] Group 2 - The share reduction was executed through centralized bidding transactions [1] - The completion date of the share reduction plan is September 24, 2025 [1] - The report indicates that the share reduction plan has been fully implemented [1]